Challenges and Opportunities for Stakeholders in Emerging Economies in Advancing Autonomous Experimentation in Biomedical Research and Health Innovation

Emerging economies are increasingly recognizing the importance of investing in science and technology to thrive in the field of biomedical research and health innovation. However, they face several challenges in entering the realm of autonomous experimentation (AE). These challenges include issues in education for science and technology, non-resilient science and technology policies, competitiveness in attracting global talents, quality of collaborations in clinical studies, health systems’ disconnection from R&D activities, and ethics, transparency, and democratic values.

Despite these challenges, there are also opportunities for stakeholders from emerging economies to join efforts in AE. These opportunities include leveraging local expertise in digital health technologies, reducing disadvantages through digital collaboration, using artificial intelligence to address global health issues, setting a science and innovation diplomacy agenda, co-producing the ethical and regulatory landscape, and promoting diversity, equity, inclusion, and trustworthiness (DEIT) in the field.

By addressing these challenges and seizing these opportunities, stakeholders from emerging economies can play a significant role in advancing AE in biomedical research and health innovation. Collaboration, investment, and a focus on ethical and inclusive practices will be key to ensuring the success of these efforts and benefiting society as a whole.